REPL Next Earnings Date Notes

— Replimune Group (Nasdaq: REPL) is a clinical-stage biotechnology company focused on developing next-generation oncolytic immunotherapies to treat cancer. Using its proprietary Immulytic�ae platform, Replimune engineers herpes simplex virus (HSV)-based therapies designed to selectively infect & kill tumor cells while inducing powerful systemic anti-tumor immune responses. The company’s lead candidates, including RP1, RP2, and RP3, are being evaluated both as monotherapies and in combination with immune checkpoint inhibitors across several difficult-to-treat cancers. For investors tracking REPL, key business metrics to watch include clinical trial progress (enrollment status, key data readouts, & milestone achievements), partnerships & collaboration agreements, updates on pipeline expansion, and cash runway/burn rate, given the company's pre-commercial status. Earnings calls are useful for gleaning management's commentary on trial timelines, regulatory feedback, and how cash resources are being allocated—critical for assessing long-term prospects. In particular, updates on any pivotal data or registration-enabling studies, changes in expected timelines, or hints about future commercialization strategies can be highly relevant for understanding Replimune's potential to achieve sustainable growth & eventual profitability. The next projected earnings date for REPL is 5/21/2026 8:00 am (stay tuned for a confirmed earnings date once announced).

REPL Next Earnings Date FAQ

On this page we presented the REPL Next Earnings Date information for Replimune Group along with recent past earnings dates. For Q3 of 2026, REPL reported earnings of -0.770/share, with the earnings report taking place on 2/3/2026. For Q2 of 2026, REPL reported earnings of -0.900/share, with the earnings report taking place on 11/6/2025. For Q1 of 2026, REPL reported earnings of -0.950/share, with the earnings report taking place on 8/7/2025. For Q4 of 2025, REPL reported earnings of -0.820/share, with the earnings report taking place on 5/22/2025. For Q3 of 2025, REPL reported earnings of -0.790/share, with the earnings report taking place on 2/12/2025. Based on these past earnings dates, the projected next earnings date for REPL is 5/21/2026 8:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Replimune Group. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Replimune Group shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Replimune Group next earnings dates as well as any other stock out there in our coverage universe, to see when the next REPL earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up REPL's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the REPL next earnings date.